Is PDLI A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Posts Tagged ‘NASDAQ:PDLI’
Hedge Funds Are Selling PDL BioPharma Inc. (PDLI)
In this article we will take a look at whether hedge funds think PDL BioPharma Inc. (NASDAQ:PDLI) is a good investment right now.
Should You Buy PDL BioPharma Inc. (PDLI)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
PDL BioPharma Inc. (PDLI) Is Burning These Hedge Funds
Is PDL BioPharma Inc. (NASDAQ:PDLI) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Were Hedge Funds Right About Flocking Into PDL BioPharma Inc. (PDLI) ?
Hedge funds are not perfect. They have their bad picks just like everyone else.
Were Hedge Funds Right About Piling Into PDL BioPharma Inc. (PDLI)?
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Hedge Funds Are Buying PDL BioPharma Inc. (PDLI)
Like everyone else, elite investors make mistakes.
Performance Of The Magic Formula Portfolio
Here’s a breakdown on how the Magic Formula Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks and is 60% invested.
The return on the invested capital is 5.
Is PDL BioPharma Inc (PDLI) Going to Burn These Hedge Funds?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Performance Of The Enterprising Investor Portfolio
Here’s a breakdown on how the Enterprising Investor Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns two stocks and is 20% invested.
The return on the invested capital is -0.90%.
Is PDL BioPharma Inc. (PDLI) Going to Burn These Hedge Funds?
We, at Insider Monkey, have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Joel Greenblatt’s Top Picks Include United Therapeutics and Activision Blizzard
One of the funds we track is Joel Greenblatt's Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter ...
Vringo, Inc. (VRNG) News: Advertisement Patents, Royalty & Google Inc (GOOG)’s Claims
Editor's Note: Vringo, Inc. (NASDAQ:VRNG), Google Inc (NASDAQ:GOOG), AOL, Inc.
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many market players, hedge funds are seen as overrated, old investment tools of a period lost to current times.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
What Hedge Funds Think About VIVUS, Inc. (VVUS)
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Alexion Pharmaceuticals, Inc. (ALXN): Extremely Expensive Drugs for Extremely Rare Diseases
The biotech industry is known for fast paced acquisitions and rapid market consolidation.
AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid
When screening for health-care dividend stocks, it's tempting to look for the ones with the highest yield.
Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
According to most stock holders, hedge funds are viewed as underperforming, old financial vehicles of the past.
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies.
PDL BioPharma Inc. (PDLI), Bridgepoint Education Inc (BPI): Magic Formula Stocks YTD and the Top 5
This article is removed because of technical problems
Do Hedge Funds and Insiders Love PDL BioPharma Inc. (PDLI)?
At the moment, there are a multitude of indicators market participants can use to track their holdings.
Santarus, Inc. (SNTS): Insiders Are Buying, Should You?
If you'd ask most shareholders, hedge funds are assumed to be underperforming, old investment tools of the past.
MannKind Corporation (MNKD), PDL BioPharma Inc. (PDLI) & Optimer Pharmaceuticals, Inc. (OPTR): 2 Biotechs to Avoid, 1 to Buy
Keeping a close eye on two particular classes of investors can tell you a lot about how stocks might move in the future.
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
PDL BioPharma Inc. (NASDAQ:PDLI): Insiders Are Dumping, Should You? – Santarus, Inc. (NASDAQ:SNTS), VIVUS, Inc. (NASDAQ:VVUS)
In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to track publicly traded companies.
Does PDL BioPharma Inc. (PDLI)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
The 25 Highest-Yielding Dividend Stocks in March: Seadrill Ltd (SDRL), Boise Inc. (BZ), Windstream Corporation (WIN)
Dividend investing is popular again.
The Fight Over This Biotech’s Cash: Elan Corporation, plc (ADR) (ELN)
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen...
